Current and historical daily PE Ratio for CMXHF (
CSL Ltd
) from 2009 to May 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CSL stock (CMXHF) PE ratio as of May 05 2024 is 36.29.
More Details
CSL Ltd (CMXHF) PE Ratio (TTM) Chart
CSL Ltd (CMXHF) PE Ratio (TTM) Historical Data
View and export this data going back to 2009. Start your Free Trial
Total 1220
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| CSL PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-05 | 35.4 | 2024-03-01 | 36.4 |
| 2024-05-03 | 35.4 | 2024-02-29 | 36.4 |
| 2024-05-02 | 34.6 | 2024-02-28 | 35.6 |
| 2024-05-01 | 34.6 | 2024-02-27 | 36.7 |
| 2024-04-30 | 34.7 | 2024-02-26 | 36.2 |
| 2024-04-29 | 34.6 | 2024-02-23 | 36.8 |
| 2024-04-26 | 34.5 | 2024-02-22 | 36.4 |
| 2024-04-25 | 35.1 | 2024-02-21 | 36.2 |
| 2024-04-24 | 35.1 | 2024-02-20 | 35.1 |
| 2024-04-23 | 34.6 | 2024-02-16 | 35.8 |
| 2024-04-22 | 34.6 | 2024-02-15 | 36.9 |
| 2024-04-19 | 34.0 | 2024-02-14 | 35.1 |
| 2024-04-18 | 34.0 | 2024-02-13 | 36.4 |
| 2024-04-17 | 33.9 | 2024-02-12 | 36.4 |
| 2024-04-16 | 34.4 | 2024-02-09 | 38.2 |
| 2024-04-15 | 35.5 | 2024-02-08 | 38.0 |
| 2024-04-12 | 35.5 | 2024-02-07 | 38.4 |
| 2024-04-11 | 35.5 | 2024-02-06 | 38.7 |
| 2024-04-10 | 37.0 | 2024-02-05 | 37.3 |
| 2024-04-09 | 35.9 | 2024-02-02 | 37.6 |
| 2024-04-08 | 35.5 | 2024-02-01 | 37.6 |
| 2024-04-05 | 35.4 | 2024-01-31 | 39.5 |
| 2024-04-04 | 36.9 | 2024-01-30 | 38.1 |
| 2024-04-03 | 36.4 | 2024-01-29 | 38.6 |
| 2024-04-02 | 36.2 | 2024-01-26 | 37.3 |
| 2024-04-01 | 36.2 | 2024-01-25 | 37.3 |
| 2024-03-28 | 36.2 | 2024-01-24 | 36.9 |
| 2024-03-27 | 36.2 | 2024-01-23 | 37.1 |
| 2024-03-26 | 36.7 | 2024-01-22 | 36.8 |
| 2024-03-25 | 35.8 | 2024-01-19 | 38.6 |
| 2024-03-22 | 36.0 | 2024-01-18 | 36.4 |
| 2024-03-21 | 34.8 | 2024-01-17 | 36.5 |
| 2024-03-20 | 35.6 | 2024-01-16 | 36.5 |
| 2024-03-19 | 35.6 | 2024-01-12 | 37.5 |
| 2024-03-18 | 35.6 | 2024-01-11 | 37.5 |
| 2024-03-15 | 36.0 | 2024-01-10 | 37.5 |
| 2024-03-14 | 36.0 | 2024-01-09 | 37.7 |
| 2024-03-13 | 36.0 | 2024-01-08 | 37.7 |
| 2024-03-12 | 36.0 | 2024-01-05 | 38.1 |
| 2024-03-11 | 36.5 | 2024-01-04 | 37.5 |
| 2024-03-08 | 36.4 | 2024-01-03 | 37.1 |
| 2024-03-07 | 36.7 | 2024-01-02 | 37.1 |
| 2024-03-06 | 35.4 | 2023-12-29 | 38.3 |
| 2024-03-05 | 36.2 | 2023-12-28 | 38.3 |
| 2024-03-04 | 34.9 | 2023-12-27 | 43.1 |
CSL Ltd (CMXHF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CSL Ltd
NAICS : 325411
ISIN : AU000000CSL8
Share Class Description:
CMXHF: Ordinary SharesCompare
Compare
Traded in other countries / regions
CSL.AustraliaCSLLY.USACSJ.GermanyCSL.Mexico IPO Date
2009-09-08Description
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers